EC Number   |
Title |
Organism |
|---|
    1.5.1.2 | Disease variants of human Delta1-pyrroline-5-carboxylate reductase 2 (PYCR2) |
Homo sapiens |
| 1.5.1.2 | Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers |
Homo sapiens |
| 1.5.1.2 | In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1 |
Homo sapiens |
| 1.5.1.2 | Peculiar substrate specificity of delta1-pyrroline-5-carboxylate reductase in the obligately fermentative bacterium Zymomonas mobilis |
Zymomonas mobilis subsp. mobilis |
| 1.5.1.2 | Peculiar substrate specificity of delta1-pyrroline-5-carboxylate reductase in the obligately fermentative bacterium Zymomonas mobilis |
Zymomonas mobilis subsp. mobilis ATCC 31821 |
| 1.5.1.2 | Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducing tumour cells |
Homo sapiens |
| 1.5.1.2 | Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome |
Homo sapiens |
| 1.5.1.2 | Pyrroline-5-carboxylate reductase-2 promotes colorectal cancer progression via activating PI3K/AKT/mTOR pathway |
Homo sapiens |
| 1.5.1.2 | Reciprocal control of thyroid binding and the pipecolate pathway in the brain |
Homo sapiens |
| 1.5.1.2 | Trypanosoma cruzi synthesizes proline via a delta1-pyrroline-5-carboxylate reductase whose activity is fine-tuned by NADPH cytosolic pools |
Trypanosoma cruzi |
